129 related articles for article (PubMed ID: 11803128)
1. Interaction of naproxen with noncrystalline acetyl beta- and acetyl gamma-cyclodextrins in the solid and liquid state.
Bettinetti G; Mura P; Faucci MT; Sorrenti M; Setti M
Eur J Pharm Sci; 2002 Feb; 15(1):21-9. PubMed ID: 11803128
[TBL] [Abstract][Full Text] [Related]
2. Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC.
Bettinetti GP; Sorrenti M; Rossi S; Ferrari F; Mura P; Faucci MT
J Pharm Biomed Anal; 2002 Nov; 30(4):1173-9. PubMed ID: 12408907
[TBL] [Abstract][Full Text] [Related]
3. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
Mura P; Faucci MT; Bettinetti GP
Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
[TBL] [Abstract][Full Text] [Related]
4. Interaction of naproxen with alpha-cyclodextrin and its noncyclic analog maltohexaose.
Bettinetti G; Sorrenti M; Negri A; Setti M; Mura P; Melani F
Pharm Res; 1999 May; 16(5):689-94. PubMed ID: 10350012
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
[TBL] [Abstract][Full Text] [Related]
6. Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers.
Mura P; Faucci MT; Maestrelli F; Furlanetto S; Pinzauti S
J Pharm Biomed Anal; 2002 Aug; 29(6):1015-24. PubMed ID: 12110386
[TBL] [Abstract][Full Text] [Related]
7. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
Mennini N; Bragagni M; Maestrelli F; Mura P
J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
[TBL] [Abstract][Full Text] [Related]
8. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
[TBL] [Abstract][Full Text] [Related]
9. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies.
Chowdary KP; Nalluri BN
Drug Dev Ind Pharm; 2000 Nov; 26(11):1217-20. PubMed ID: 11068697
[TBL] [Abstract][Full Text] [Related]
10. Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution.
Bettinetti G; Melani F; Mura P; Monnanni R; Giordano F
J Pharm Sci; 1991 Dec; 80(12):1162-70. PubMed ID: 1815076
[TBL] [Abstract][Full Text] [Related]
11. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
[TBL] [Abstract][Full Text] [Related]
12. Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state.
Mura P; Furlanetto S; Cirri M; Maestrelli F; Corti G; Pinzauti S
J Pharm Biomed Anal; 2005 Apr; 37(5):987-94. PubMed ID: 15862677
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties.
Mura P; Zerrouk N; Mennini N; Maestrelli F; Chemtob C
Eur J Pharm Sci; 2003 May; 19(1):67-75. PubMed ID: 12729863
[TBL] [Abstract][Full Text] [Related]
14. Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets.
Dahiya S; Pathak K
Pharmazie; 2007 Apr; 62(4):278-83. PubMed ID: 17484283
[TBL] [Abstract][Full Text] [Related]
15. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
17. Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.
Reddy MN; Rehana T; Ramakrishna S; Chowdhary KP; Diwan PV
AAPS PharmSci; 2004 Mar; 6(1):E7. PubMed ID: 15198508
[TBL] [Abstract][Full Text] [Related]
18. Inclusion complexation of nimesulide with beta-cyclodextrins.
Vavia PR; Adhage NA
Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
[TBL] [Abstract][Full Text] [Related]
19. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
Veiga MD; Ahsan F
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
[TBL] [Abstract][Full Text] [Related]
20. Effects of grinding with microcrystalline cellulose and cyclodextrins on the ketoprofen physicochemical properties.
Mura P; Faucci MT; Parrini PL
Drug Dev Ind Pharm; 2001 Feb; 27(2):119-28. PubMed ID: 11266223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
